Origen de la red de primer grado Wim Vermeulen.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Erasmus University Rotterdam
63
| College/University | Other Consumer Services | 63 |
DNage BV
 DNage BV Miscellaneous Commercial ServicesCommercial Services DNage is a life sciences company founded in 2004 as a spin off from the Department of Genetics of the Erasmus Medical Center Rotterdam. The Company was seed-funded through an equity investment of an international syndicate of venture capitalists including LSP (NL) and Inventages (CH). The Company's main scientific founder Prof J. Hoeijmakers is a world-renowned scientist working on DNA repair and genome stability. His team was the first to establish an explicit connection between DNA damage (lack of repair) and the process of ageing, a scientific breakthrough. DNage has acquired exclusive access to this technology and now focuses on developing therapies to reduce the effects of ageing, leveraging the unique technologies developed by its founders. DNage has matured from an early stage technology company into a drug development company with ongoing clinical trials and several research programs. It has been acquired by Pharming Group NV in October 2006 and is currently involved in a financing round whereby Pharming will reduce its ownership to a non-controlling stake. The team of the company consists of approximately 15 people. DNage has laboratory facilities and offices in Rotterdam and Leiden, The Netherlands.
14
| Extinct | Miscellaneous Commercial Services | 14 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Wim Vermeulen a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ING GROEP N.V. | Major Banks | Corporate Officer/Principal Corporate Officer/Principal | |
| Nyenrode Business Universiteit | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
| NN GROUP N.V. | Life/Health Insurance | Chief Executive Officer Corporate Officer/Principal | |
Van Lanschot Kempen Investment Management NV
 Van Lanschot Kempen Investment Management NV Investment ManagersFinance Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities Chief Executive Officer | |
Nationale Nederlanden NV
 Nationale Nederlanden NV Financial ConglomeratesFinance Nationale Nederlanden NV provides insurance services. The firm offers life, property, and casualty insurance services as well as mortgages. It also has operating facility in Rotterdam. The company was founded in 1962 and is headquartered in The Hague, the Netherlands. | Financial Conglomerates | Corporate Officer/Principal Director/Board Member | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies. | Investment Managers | Private Equity Investor Private Equity Investor | |
Robeco Global Stars Equities Fund NV
 Robeco Global Stars Equities Fund NV Investment Trusts/Mutual FundsMiscellaneous Robeco Global Stars Equities Fund NV engages in the management of investment funds such as stocks, bonds, and alternative funds. The company is headquartered in Rotterdam, the Netherlands. | Investment Trusts/Mutual Funds | Chief Operating Officer Corporate Officer/Principal | |
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| PHARMING GROUP N.V. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
AlpInvest Partners BV
 AlpInvest Partners BV Investment ManagersFinance AlpInvest Partners BV (AlpInvest) is a private equity asset subsidiary AP BV, ultimately owned by The Carlyle Group, Inc founded in 2000. AlpInvest Partners BV is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| University of Tilburg | College/University | Masters Business Admin Doctorate Degree | |
ING Bank NV
 ING Bank NV Major BanksFinance ING Bank NV engages in the provision of banking, investment, life insurance, and retirement services. It operates through the following segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The Retail Netherlands segment offers current and savings accounts, business lending, mortgages, and other consumer lending in the Netherlands. The Retail Belgium segment focuses in the retail and private banking activities in Belgium and offered services like the Netherland segment. The Retail Germany segment consists of current and savings accounts, mortgages, and other customer lending. The Retail Other segment comprises income from retail banking activities in the rest of the world, including the SME and mid-corporate segments. The Wholesale Banking segment include income from wholesale banking activities (a full range of products is offered from cash management to corporate finance), real estate, and lease. The Corporate Line Banking segment comprises corporate line banking and the run-off portfolio of Real Estate. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Major Banks | Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal | |
| University of Amsterdam | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| NIBC HOLDING N.V. | Investment Banks/Brokers | Director/Board Member Corporate Officer/Principal | |
| University of Utrecht | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
| University of Groningen | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
AlpInvest US Holdings LLC
 AlpInvest US Holdings LLC Investment ManagersFinance AlpInvest Partners, Inc. (AlpInvest) is the New York City private equity subsidiary of Netherlands-based AlpInvest Partners BV, ultimately held by The Carlyle Group LP (NASDAQ: CG). Established in 1999 as NIB Capital Private Equity, the firm became AlpInvest Partners in 2004. They were the first exclusive private equity manager for a public pension fund and invest worldwide across primary funds, secondaries, and direct investment (co-investment) channels, covering the entire private equity spectrum. In addition to the New York office, AlpInvest has offices in Amsterdam, Hong Kong and London. They are a socially responsible investor which works to promote sustainability and governance as an important factor in investment choices. They are a signatory to the UN Principles for Responsible Investments and exclude direct investments in companies that are directly involved in the manufacturing or distribution of products that clearly violate Dutch and relevant international conventions. They also explore sustainability-themed investments. | Investment Managers | Chairman Investment Committee Member | |
| Promontoria Investments I BV | Chief Executive Officer | ||
| Promontoria Investments II BV | Chief Executive Officer | ||
| Promontoria Investments III BV | Chief Executive Officer | ||
| Robeco Nederland BV | Chief Executive Officer Director/Board Member | ||
| Dutch Fund & Asset Management Association | Director/Board Member Chairman | ||
| ABN AMRO BANK N.V. | Major Banks | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Promontoria Blue 28 BV | Chief Executive Officer | ||
| Promontoria Blue 29 BV | Chief Executive Officer | ||
| Promontoria Blue 30 BV | Chief Executive Officer | ||
| Promontoria Blue 31 BV | Chief Executive Officer | ||
| Promontoria Blue 32 BV | Chief Executive Officer | ||
| Promontoria Holding 36 BV | Chief Executive Officer | ||
| Promontoria Blue 33 BV | Chief Executive Officer | ||
| Promontoria Blue 34 BV | Chief Executive Officer | ||
| Promontoria Holding 35 BV | Chief Executive Officer | ||
| Promontoria Blue 35 BV | Chief Executive Officer | ||
| Promontoria Holding 34 BV | Chief Executive Officer | ||
| Promontoria Blue 36 BV | Chief Executive Officer | ||
| Promontoria Blue 37 BV | Chief Executive Officer | ||
| Promontoria Blue 38 BV | Chief Executive Officer | ||
| Promontoria Holding XXXIII BV | Chief Executive Officer | ||
| Promontoria Blue 39 BV | Chief Executive Officer | ||
| Promontoria Blue 40 BV | Chief Executive Officer | ||
| Promontoria Holding XXXI BV | Chief Executive Officer | ||
| Promontoria Blue 41 BV | Chief Executive Officer | ||
| Promontoria Blue 42 BV | Chief Executive Officer | ||
| Promontoria Holding XXX BV | Chief Executive Officer | ||
| Promontoria Blue 43 BV | Chief Executive Officer | ||
| Promontoria Holding XXIX BV | Chief Executive Officer | ||
| Promontoria Blue 44 BV | Chief Executive Officer | ||
VitalneXt BV
 VitalneXt BV Pharmaceuticals: GenericHealth Technology VitalneXt BV develops retails and manufactures products for healthy ageing. Its products include promanna, vital01 and other products. The firm develops products with evidence-based health benefits for the ageing population. It also develops new, proprietary, technologies, ingredients and products through its own network and through collaborations with the company's research partners. The company was founded by Rein Strijker in May 2013 and is headquartered in Amersfoort, the Netherlands. | Pharmaceuticals: Generic | Chief Executive Officer Corporate Officer/Principal | |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor |
Estadísticas
Internacional
| Países Bajos | 50 |
| Estados Unidos | 2 |
Sectorial
| Finance | 13 |
| Consumer Services | 6 |
| Health Technology | 4 |
| Miscellaneous | 2 |
Operativa
| Director/Board Member | 209 |
| Chief Executive Officer | 161 |
| Corporate Officer/Principal | 105 |
| Graduate Degree | 45 |
| Private Equity Investor | 40 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Geert-Jan Schipper | 135 |
| Leni M. T. Boeren | 32 |
| René Kuijten | 30 |
| Johan Henrik Andresen | 23 |
| Helen Tveitan-de Jong | 22 |
| Caspar Antonius Berendsen | 20 |
| Robert Schier | 20 |
| Mariken Tannemaat | 19 |
| David Knibbe | 18 |
| Boudewijn Clemens Wentink | 16 |
| Erik Esveld | 15 |
| Mark Wegter | 11 |
| Pieter Muntendam | 11 |
| Brent Wissink | 11 |
| Mark Jans | 10 |
- Bolsa de valores
- Insiders
- Wim Vermeulen
- Conexiones Empresas
